Cargando…
Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma
Autores principales: | Eberst, Lauriane, Cassier, Philippe A, Brahmi, Mehdi, Tirode, Franck, Blay, Jean-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299035/ https://www.ncbi.nlm.nih.gov/pubmed/32546510 http://dx.doi.org/10.1136/esmoopen-2020-000756 |
Ejemplares similares
-
Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma
por: Sabe, Hideaki, et al.
Publicado: (2021) -
Aneurysmal ("angiomatoid") fibrous histiocytoma in a child.
por: Kim, C. J., et al.
Publicado: (1989) -
Subcutaneous Angiomatoid Fibrous Histiocytoma Mimicking Metastatic Melanoma
por: Sparreboom, E., et al.
Publicado: (2012) -
Angiomatoid Fibrous Histiocytoma: A Series of Three Cases
por: Alzahim, Mohammed A, et al.
Publicado: (2021) -
PD-L1 expression in angiomatoid fibrous histiocytoma
por: Byers, Joshua, et al.
Publicado: (2021)